AKT1 and breast carcinoma: Moreover, downstream signaling of PODXL2 in breast cancer was simulated by the ClueGo and CluePedia databases in Figure 6E. A combination of the ClueGo, CluePedia, and GO pathways showed that PODXL2 interacted with NANOG, AKT1, and RAC1.